Studies Find 5-MeO-DMT Improves Symptoms of Anxiety and Depression
Improvements in depression and anxiety are associated with greater intensity of mystical experiences and higher ratings of the spiritual significance and personal meaning.
Mental Health - Page 12
TheraPsil Seeks Permission From Health Canada to Use Psilocybin Treatments for Dying Patients
Bruce Tobin is asking Health Canada to approve psilocybin to treat anxiety and depression in end-of-life patients.
Analysis of the Future Psilocybin Pharmaceutical Market
FDA approval for psilocybin-assisted therapy for depression appears to be on the horizon.
Johns Hopkins Researchers Call for Rescheduling Psilocybin
Researchers push to move psilocybin from Schedule I to Schedule IV if Phase III clinical trials are successful.
Psilocybin Receives FDA Breakthrough Treatment Designation
The FDA will work to expedite the development and review of the drug so it can get to patients as soon as possible.
Study Suggests Psilocybin Resets the Brain in Depressed People
Researchers measured the effects of psilocybin in depressed people by comparing brain scan data.